Mercado, Nicolas http://orcid.org/0000-0002-8728-0994
Schutzius, Gabi http://orcid.org/0000-0001-7867-6199
Kolter, Christian http://orcid.org/0000-0001-5174-6126
Estoppey, David http://orcid.org/0000-0002-6631-7487
Bergling, Sebastian http://orcid.org/0000-0002-6840-3266
Roma, Guglielmo http://orcid.org/0000-0002-8020-4219
Gubser Keller, Caroline
Nigsch, Florian http://orcid.org/0000-0002-2919-8749
Salathe, Adrian http://orcid.org/0000-0001-5715-7883
Terranova, Remi http://orcid.org/0000-0002-2119-679X
Reece-Hoyes, John
Alford, John
Russ, Carsten
Knehr, Judith
Hoepfner, Dominic http://orcid.org/0000-0001-8450-7543
Aebi, Alexandra http://orcid.org/0000-0001-8078-8739
Ruffner, Heinz
Beck, Tanner C.
Jagannathan, Sajjeev
Olson, Calla M.
Sheppard, Hadley E.
Elsarrag, Selma Z.
Bouwmeester, Tewis
Frederiksen, Mathias http://orcid.org/0000-0002-2076-3748
Lohmann, Felix
Lin, Charles Y. http://orcid.org/0000-0002-9155-090X
Kirkland, Susan http://orcid.org/0000-0003-1464-1063
Article History
Received: 9 November 2018
Accepted: 14 September 2019
First Online: 14 October 2019
Competing interests
: Most authors (with the exception of C.Y.L., T.B., S.J., C.M.O., H.E.S., S.E., all Baylor, TX) were employees of Novartis during the course of this work, as indicated in the affiliations. C.Y.L. received sponsored travel from Novartis and is a shareholder and inventor of IP licensed to Syros Pharmaceuticals. Some authors own shares in Novartis. The remaining authors declare no competing interests.